TP53 and neoplasm: By interacting with the histone methyltransferase EZH2 (Enhancer of zeste homolog 2) at the p53 gene promoter, EZH2 mediates the addition of methyl groups to histone H3 at lysine 27 and suppresses its transcriptional activity, thus affecting the tumor-suppressive role of p53 [92].